BlackRock Discloses Significant Passive Stake in Adaptive Biotechnologies
Ticker: ADPT · Form: SC 13G · Filed: Jan 26, 2024 · CIK: 1478320
| Field | Detail |
|---|---|
| Company | Adaptive Biotechnologies Corp (ADPT) |
| Form Type | SC 13G |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: institutional-ownership, passive-investment, SC-13G
TL;DR
**BlackRock owns a chunk of Adaptive Biotech, signaling institutional confidence.**
AI Summary
BlackRock Inc., a massive investment firm, reported on January 26, 2024, that it holds a significant stake in Adaptive Biotechnologies Corp. as of December 31, 2023. This filing indicates BlackRock's passive ownership, meaning they aren't trying to influence the company's management. For investors, this shows a major institutional player has confidence in Adaptive Biotechnologies, potentially signaling stability or future growth prospects for the stock.
Why It Matters
When a giant like BlackRock holds a stock, it often lends credibility and can attract other investors, potentially boosting the stock's value.
Risk Assessment
Risk Level: low — This filing indicates a large, passive institutional investment, which generally reduces risk by providing stability and a vote of confidence.
Analyst Insight
A smart investor would view BlackRock's passive stake as a positive signal, suggesting fundamental stability, and might consider further research into Adaptive Biotechnologies' business prospects.
Key Players & Entities
- BlackRock Inc. (company) — the investment firm filing the SC 13G
- Adaptive Biotechnologies Corp (company) — the subject company in which BlackRock holds shares
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the filing date of the SC 13G
Forward-Looking Statements
- BlackRock will maintain its passive stake in Adaptive Biotechnologies for the foreseeable future. (BlackRock Inc.) — high confidence, target: 2025-12-31
FAQ
What type of filing is this document?
This document is an SC 13G filing, specifically designated under Rule 13d-1(b) as indicated by the '[X] Rule 13d-1(b)' checkbox.
Who is the 'subject company' in this filing?
The subject company, whose securities are being reported, is Adaptive Biotechnologies Corp., with CIK 0001478320.
Who is the 'filing company' or 'reporting person'?
The filing company, or reporting person, is BlackRock Inc., with CIK 0001364742.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of Adaptive Biotechnologies Corp. is 00650F109.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on January 26, 2024 regarding Adaptive Biotechnologies Corp (ADPT).